Skip to main content
Log in

Urinary excretion of frusemide and its metabolites in a diabetic nephropathy patient

  • Letters To The Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Smith DE, Lin ET, Benet LZ (1980) Absorption and disposition of furosemide in healthy volunteers, measured with a metabolite specific assay. Drug Metab Dispos 8: 337–342

    Google Scholar 

  2. Andreasen F, Christensen CK, Jakobsen FK, Mogensen CE (1981) The use of HPLC to elucidate the metabolism and urinary excretion of furosemide and its metabolic products. Acta Pharmacol Toxicol 49: 223–229

    Google Scholar 

  3. Nakahama H, Miwa Y, Yamaji A, Orita Y, Fukuhara Y, Yanase M, Kamada T, Sonoda T, Ishibashi M, Ichikawa Y, Takahara S (1987) The urinary excretion of frusemide and its metabolites by kidney transplant patients. Eur J Clin Pharmacol 32: 313–315

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nakahama, H., Orita, Y., Izumi, M. et al. Urinary excretion of frusemide and its metabolites in a diabetic nephropathy patient. Eur J Clin Pharmacol 35, 113 (1988). https://doi.org/10.1007/BF00555520

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00555520

Key words

Navigation